Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil
COMPLERA
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$130.5185
No Shortage
Tier 1: 0.3%
Emtricitabine, Rilpivirine Hydrochloride, and Tenofovir Disoproxil blocks HIV replication by inhibiting reverse transcriptase.
vs. brand COMPLERA: Generic saves up to -1205% per unit
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.